Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD

Publisher： Karger

E-ISSN： 1423-0356|73|4|414-419

ISSN： 0025-7931

Source： Respiration, Vol.73, Iss.4, 2006-07, pp. : 414-419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Formoterol and Salmeterol in Partially Reversible Chronic Obstructive Pulmonary Disease: A Crossover, Placebo-Controlled Comparison of Onset and Duration of Action

By  

Respiration, Vol. 66, Iss. 5, 1999-09 ,pp. : 434-439

Karger

Access to resources Recommend Favorite

N-Acetylcysteine Reduces the Exacerbation Rate in Patients with Moderate to Severe COPD

By  

Respiration, Vol. 66, Iss. 6, 1999-11 ,pp. : 495-500

Karger

Access to resources Recommend Favorite

Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial

By Pertseva Tetyana   Dissanayake Sanjeeva   Kaiser Kirsten  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1357-1369

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation

By  

Respiration, Vol. 91, Iss. 1, 2016-0 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Neutrophil Activation in Severe, Early-Onset COPD Patients versus Healthy Non-Smoker Subjects in vitro: Effects of Antioxidant Therapy

By  

Respiration, Vol. 83, Iss. 2, 2011-11 ,pp. : 147-158

Karger

Access to resources Recommend Favorite